These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 2371263)

  • 21. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on drug interactions.
    Venkatesan K; Bharadwaj VP; Ramu G; Desikan KV
    Lepr India; 1980 Apr; 52(2):229-35. PubMed ID: 7453137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of multiple regimens in leprosy.
    Ramu G; Sreevatsa ; Sengupta U; Desikan KV
    Lepr India; 1981 Apr; 53(2):190-6. PubMed ID: 6166790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K; Natarajan M; Bagga A; Katoch VM
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
    Jamet P; Blanc L; Fayne OC; Traore I; Bobin P
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
    Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
    Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
    Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
    Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
    Medeiros S; Catorze MG; Vieira MR
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
    Ganapati R; Pai VV; Banerji U; Thomas J; Saha B
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):495-7. PubMed ID: 9465161
    [No Abstract]   [Full Text] [Related]  

  • 35. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial with clofazimine in leprosy.
    Ganapati R; Dongre VV
    Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.